Related Experiment Video
Updated: Jan 8, 2026

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Dysregulated Intestinal Nutrient Absorption in Obesity Is Associated with Altered Chromatin Accessibility.
Dilhana S Badurdeen1, Zhen Li1, Jeong-Heon Lee2
1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
Obese individuals with a hyperabsorptive phenotype show increased nutrient absorption in the gut. This is linked to specific gene expression changes and chromatin accessibility in intestinal cells, offering new therapeutic targets for obesity.
Area of Science:
- Gastroenterology
- Metabolic Diseases
- Epigenetics
Background:
- Obesity is a widespread epidemic with diverse health consequences.
- Individual obese phenotypes and their therapeutic responses are poorly understood.
- Epigenetic alterations in obesity are observed across multiple tissues, but intestinal epithelial features remain unclear.
Purpose of the Study:
- To investigate the transcriptional and epigenomic characteristics of intestinal organoids from non-obese, obese, and obese hyperabsorptive individuals.
- To identify molecular features associated with the obese hyperabsorption phenotype in the gut.
Main Methods:
- Human intestinal organoids were established from donors classified by BMI and glucose transport assays.
- Transcriptomic analysis (gene expression) and chromatin accessibility assays were performed.
- Transcription factor binding and quantitative RT-PCR were used to validate findings.
Main Results:
- Obese hyperabsorptive organoids exhibited upregulated nutrient absorption transcripts and downregulated type I interferon targets.
- Chromatin accessibility suggested enhanced HNF4G binding may drive the hyperabsorption phenotype.
- Expression of CUBN, GIP, SLC5A11, and SLC2A5 in intestinal epithelia strongly correlated with hyperabsorption.
Conclusions:
- The obese hyperabsorption phenotype is characterized by transcriptional shifts promoting increased intestinal nutrient uptake.
- Differential chromatin accessibility may underlie these transcriptional changes.
- Identifying distinct intestinal phenotypes in obesity offers novel therapeutic strategies.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Glucose Absorption Into the Small Intestine
Obesity
Epigenetic Regulation
X-chromosome...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Spreading of Chromatin Modifications
Writers
The writer...

